About
Adtrinib is a highly selective targeted therapeutic agent, primarily functioning as a tyrosine kinase inhibitor (TKI). It is meticulously designed to interfere with specific signaling pathways that are aberrantly activated in various cancer cells, driving their uncontrolled growth, proliferation, and survival. By precisely blocking the activity of these overactive enzymes, Adtrinib effectively disrupts critical cellular processes such as cell division, angiogenesis (the formation of new blood vessels that feed tumors), and metastatic spread. This mechanism offers a more refined and targeted approach to oncology compared to traditional chemotherapy, aiming to minimize damage to healthy tissues while effectively controlling disease progression. Its clinical application is often guided by comprehensive biomarker testing to identify patients whose tumors harbor the specific genetic mutations or molecular alterations that make them susceptible to Adtrinib's inhibitory profile, thereby maximizing therapeutic benefit and patient response rates.
Uses
- Treatment of advanced solid tumors.
- Management of certain hematologic malignancies.
- Adjuvant therapy in specific cancer settings.
- Palliative treatment for metastatic disease.
Directions For Use
Take orally once daily, with or without food, as prescribed by your doctor. Swallow the tablet whole; do not crush or chew.
Benefits
- Targeted action against cancer cells.
- Potential for improved progression-free survival.
- Oral administration convenience.
- May offer an option for resistant cancers.
- Reduced systemic toxicity compared to traditional chemotherapy.
- Improved disease control in responsive patients.
Side Effects
- Fatigue
- Nausea
- Diarrhea
- Skin rash
- Headache
- Hypertension
- Edema
- Abdominal pain
- Anemia
- Thrombocytopenia
- Neutropenia
- Elevated liver enzymes
Safety Measures
- Alcohol - Avoid or limit alcohol consumption as it may exacerbate liver side effects or interact with the medication.
- Pregnancy - Not recommended during pregnancy due to potential fetal harm. Effective contraception is advised for women of childbearing potential.
- Breastfeeding - Breastfeeding is generally not recommended during treatment due to the potential for drug excretion into breast milk and harm to the infant.
- Liver - Use with caution in patients with pre-existing liver impairment; dose adjustments may be necessary, and liver function should be monitored regularly.
- Kidney - Use with caution in patients with renal impairment; dose adjustments may be required based on the degree of kidney dysfunction.
- Lung - Monitor for new or worsening pulmonary symptoms, as interstitial lung disease or pneumonitis can be rare but serious side effects.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!